Overview of influenza vaccination policy in Beijing, China: Current status and future prospects

Journal of Public Health Policy
Yi ZhangC Raina Macintyre

Abstract

Vaccination is the best available way to prevent influenza infections and related complications. Little information is available on vaccination policy in the world's most populous country, China. In China, influenza vaccine is not included in the national immunization programme. Citizens seek the vaccine on their own. Since 2007, Beijing, ahead of most cities in China, has offered free influenza vaccine for seniors aged at least 60 years and for primary and middle school students. There has been limited evaluation of the policy. We introduce and evaluate the government-funded influenza immunization policy in Beijing. Available data showed that the policy greatly increased the vaccine uptake rate in the population qualifying for free vaccination. Evidence of impact in a single influenza season on all high-risk populations was unclear. We suggest that further evaluation over multiple influenza seasons and in each high-risk group are required to inform future policy development in Beijing.

References

Dec 4, 2003·Lancet·Karl G NicholsonMaria Zambon
Jul 29, 2005·The International Journal of Social Psychiatry·Kam-Shing Yip
Apr 22, 2010·JAMA : the Journal of the American Medical Association·Alicia M SistonUNKNOWN Pandemic H1N1 Influenza in Pregnancy Working Group
Apr 27, 2010·Occupational Medicine·H SealeC R MacIntyre
Oct 30, 2010·Emerging Infectious Diseases·Xiaoli WangQuanyi Wang
Dec 17, 2010·The New England Journal of Medicine·Jiang WuYing Deng
Jan 12, 2011·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Hongjie YuYu Wang
Apr 20, 2011·The Brazilian Journal of Infectious Diseases : an Official Publication of the Brazilian Society of Infectious Diseases·Peng YangQuanyi Wang
Apr 19, 2012·Bulletin of the World Health Organization·Luzhao FengHongjie Yu
Jun 30, 2012·American Journal of Infection Control·Joseph T F LauK C Choi
Jan 31, 2013·Journal of Public Health Management and Practice : JPHMP·Megan C Lindley
Sep 11, 2013·Vaccine·Carol Yuet Sheung YuenMarie Tarrant
Sep 21, 2013·Emerging Infectious Diseases·Shui Shan LeeSing Lee
Jun 27, 2014·Vaccine·Zhiyuan HouYuting Zhang
Sep 5, 2014·Euro Surveillance : Bulletin Européen Sur Les Maladies Transmissibles = European Communicable Disease Bulletin·N TurnerUNKNOWN SHIVERS investigation team
Nov 20, 2014·The Journal of Infectious Diseases·Huong Q McLeanEdward A Belongia
Jan 20, 2015·International Journal of Environmental Research and Public Health·Yi ZhangQuanyi Wang
Feb 14, 2015·Euro Surveillance : Bulletin Européen Sur Les Maladies Transmissibles = European Communicable Disease Bulletin·S A McNeilUNKNOWN Investigators of the Serious Outcomes Surveillance Network of the Canadian Immunization Research Network (CIRN)
Mar 17, 2015·Journal of Infection in Developing Countries·Yang PanQuanyi Wang
Jun 5, 2015·Human Vaccines & Immunotherapeutics·Luzhao FengHongjie Yu
Sep 15, 2015·Vaccine·Abraham PalacheUNKNOWN Influenza Vaccine Supply task force (IFPMA IVS)
Jul 30, 2016·The Journal of Infectious Diseases·Huong Q McLeanEdward A Belongia

❮ Previous
Next ❯

Citations

Jun 16, 2018·Influenza and Other Respiratory Viruses·Yi ZhangC Raina MacIntyre
Apr 2, 2020·Aging Medicine·Qiong ChenUNKNOWN Recommendations for Influenza, Streptococcus pneumoniae Vaccination in Elderly People in China Writing Group, Geriatric Resp
Aug 28, 2020·The Journal of International Medical Research·Xinxin LiQingjun Pan
Dec 4, 2020·Human Vaccines & Immunotherapeutics·Sijin YanChuchu Ye

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.